Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Living Near Fracking Tied to Increase in Hospitalizations in Seniors

Older adults living near fracking sites could have a high risk for poor cardiovascular outcomes, according to a study published in the March issue of The...

Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA for patients with cancer

 BEIJING, SHANGHAI and BOSTON, March 22, 2023. Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co.,...

Novartis Tafinlar + Mekinist Approved by FDA for Pediatric Patients with BRAF V600E Low-Grade Glioma

New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median progression-free survival (mPFS) of 20.1 months for Tafinlar...

FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)

(BUSINESS WIRE)--Mar. 22, 2023-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz™ (retifanlimab-dlwr),...

First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia

CAPE CANAVERAL, Fla., March 20, 2023. Vaxxinity, Inc., a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced...

Developmental Delay Tied to Higher Complication Rate With Tonsillectomy

Children with developmental delay (DD) have a significantly higher complication rate with tonsillectomy compared with children without DD, according to...

Green Space, Tree Coverage Tied to Lower Risk for Postpartum Depression

Street view-based green space and tree coverage are associated with a decreased risk for postpartum depression (PPD), according to a study published online...

Electronic Reminders Boost Flu Vaccine Uptake in Older Adults

Electronically delivered letter reminders significantly increase vaccination uptake among older adults in Denmark, according to a study published online...

Greater Adiposity Linked to Worse Outcomes in Patients With HFrEF

For patients with heart failure with reduced ejection fraction (HFrEF), waist-to-height ratio shows no evidence for an obesity-survival paradox, according...

Minimal Residual Disease Negativity Predicts Time to Next Treatment in Multiple Myeloma

For patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer...

Exercise Affects Positive and Negative Symptoms of Schizophrenia

For patients with schizophrenia, exercise has a significant effect on positive and negative symptoms, according to a review published online Feb. 20 in...

CDC Report Looks at Financial Burden of Medical Care Faced by Veterans

Financial burden of care is similar or lower for veterans with Veterans Affairs (VA) health care only or Tricare than those with private insurance, according...

Salt Restriction Linked to Drop in BP in Primary Aldosteronism

For patients with primary aldosteronism, dietary salt restriction is associated with a reduction in blood pressure, according to a study published online...

Progestogen-Only Contraceptives May Slightly Increase Breast Cancer Risk

Progestogen-only contraceptive use is associated with a slight increase in breast cancer risk, according to a study published online March 21 in PLOS Medicine. Danielle...

Scientists Pinpoint Brain Area Needed for Vision-Guided Walking

A new study hones in on what part of your brain controls walking. Researchers discovered that two main regions of the cortex were activated as people...

Exercise Does Help People With Parkinson's Disease, Review Finds

Exercise can help improve movement-related symptoms for people who have Parkinson’s disease, a new review finds. And any type of structured exercise...

When BMI Isn't Used as Measurement, Obesity's Health 'Benefit' Disappears

Much has been made of the so-called “obesity paradox” -- the observation that people with a heart condition seem less likely to die if they...

Death Count Climbs in Outbreak Linked to Recalled Eyedrops

WEDNESDAY, March 22, 2023 – A drug-resistant bacteria linked to recalled eye drops has now killed three people. The U.S. Centers for Disease Control...

Birth Control Pills Tied to Slight Rise in Breast Cancer Risk, Regardless of Formulation

Taking progestogen-only birth control pills comes with a slightly increased risk of breast cancer -- about the same degree of risk associated with taking...

Similar Processes Could Link MS With Heart Disease

Multiple sclerosis (MS) and atherosclerosis both involve an abnormal hardening of body tissue, and recent research suggests they may be linked. MS is...

Read more news...

Recently Added

Recently added consumer and prescribing information: Daybue, Zavzpret, Combogesic, Skyclarys, Filspari, Jaypirca, Brenzavvy, Briumvi, Airsupra, Leqembi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Zynyz Zynyz (retifanlimab-dlwr) is a programmed death receptor-1 (PD-1)–blocking antibody for the treatment of Merkel cell carcinoma.
  • Daybue Daybue (trofinetide) is a synthetic analog of the amino‐terminal tripeptide of IGF-1 for the treatment of Rett syndrome.
  • Zavzpret Zavzpret (zavegepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine.

More FDA approvals

Drugs in Development (Not yet approved)

  • Lumryz Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for...
  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development